<DOC>
	<DOC>NCT00301223</DOC>
	<brief_summary>The objective of this study is to evaluate the efficacy, safety and tolerability for pregabalin using a flexible, optimized dose schedule compared to placebo in relieving the symptoms of neuropathic pain.</brief_summary>
	<brief_title>A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Chinese outpatient of age 18 to 75 At screening and baseline, a score of greater than 40 mm on the visual log scale of SFMPQ Neurologic disorders unrelated to neuropathic pain, which in the opinion of the investigator, might impair the assessment of pain Serum creatinine clearance greater than 60 ml/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>